Collaborative Drug Discovery (CDD) is hosting their users and community meeting at the UCSF Mission Bay Conference Center in San Francisco on...

If you hobnob around scientists, you might be increasingly hearing the mysterious acronym “CRISPR” being mentioned in conversation. CRISPR...

Previously, we discussed in part 1 of this series the growing significance of computational methods in drug discovery. Traditional drug discovery...

Published in The Coast News last week, was a great article about how Bio, Tech and Beyond, the darling incubator lab of San Diego, is providing...

Most people have probably heard of Alexander Fleming’s chance encounter with a penicillin-producing fungus. What is not quite well-known is that...

Traditional drug discovery is expensive, inefficient, and has huge barriers to entry. Big pharmaceutical companies continue to struggle to cope...

A quick scan of recent advances in the scientific community will show that genomic data and new techniques in next-gen sequencing have been gaining...

This is the third and final post of a series (part 1 and part 2) on directed evolution. What do protein engineers actually produce using directed...

Three outstanding examples for fragment-based drug discovery A good example for the reliability of the fragment-based screening method is the...

Directed evolution is emerging as a powerful new tool to design proteins with new and interesting properties that may not have evolved naturally...